Department for Molecular Biomedical Research, VIB-Ghent University, Technologiepark 927, Zwijnaarde-Ghent, Belgium.
Cell Death Differ. 2013 Oct;20(10):1381-92. doi: 10.1038/cdd.2013.94. Epub 2013 Jul 26.
Receptor-interacting protein kinase (RIPK) 1 and RIPK3 have emerged as essential kinases mediating a regulated form of necrosis, known as necroptosis, that can be induced by tumor necrosis factor (TNF) signaling. As a consequence, inhibiting RIPK1 kinase activity and repressing RIPK3 expression levels have become commonly used approaches to estimate the contribution of necroptosis to specific phenotypes. Here, we report that RIPK1 kinase activity and RIPK3 also contribute to TNF-induced apoptosis in conditions of cellular inhibitor of apoptosis 1 and 2 (cIAP1/2) depletion or TGF-β-activated kinase 1 (TAK1) kinase inhibition, implying that inhibition of RIPK1 kinase activity or depletion of RIPK3 under cell death conditions is not always a prerequisite to conclude on the involvement of necroptosis. Moreover, we found that, contrary to cIAP1/2 depletion, TAK1 kinase inhibition induces assembly of the cytosolic RIPK1/Fas-associated protein with death domain/caspase-8 apoptotic TNF receptor 1 (TNFR1) complex IIb without affecting the RIPK1 ubiquitylation status at the level of TNFR1 complex I. These results indicate that the recruitment of TAK1 to the ubiquitin (Ub) chains, and not the Ub chains per se, regulates the contribution of RIPK1 to the apoptotic death trigger. In line with this, we found that cylindromatosis repression only provided protection to TNF-mediated RIPK1-dependent apoptosis in condition of reduced RIPK1 ubiquitylation obtained by cIAP1/2 depletion but not upon TAK1 kinase inhibition, again arguing for a role of TAK1 in preventing RIPK1-dependent apoptosis downstream of RIPK1 ubiquitylation. Importantly, we found that this function of TAK1 was independent of its known role in canonical nuclear factor-κB (NF-κB) activation. Our study therefore reports a new function of TAK1 in regulating an early NF-κB-independent cell death checkpoint in the TNFR1 apoptotic pathway. In both TNF-induced RIPK1 kinase-dependent apoptotic models, we found that RIPK3 contributes to full caspase-8 activation independently of its kinase activity or intact RHIM domain. In contrast, RIPK3 participates in caspase-8 activation by acting downstream of the cytosolic death complex assembly, possibly via reactive oxygen species generation.
受体相互作用蛋白激酶(RIPK)1 和 RIPK3 已成为介导受调控形式坏死的关键激酶,这种坏死形式被称为坏死性凋亡,可由肿瘤坏死因子(TNF)信号诱导。因此,抑制 RIPK1 激酶活性和抑制 RIPK3 表达水平已成为常用的方法来评估坏死性凋亡对特定表型的贡献。在这里,我们报告 RIPK1 激酶活性和 RIPK3 也有助于细胞凋亡抑制因子 1 和 2(cIAP1/2)耗竭或 TGF-β激活激酶 1(TAK1)激酶抑制诱导的 TNF 诱导的细胞凋亡,这意味着在细胞死亡条件下抑制 RIPK1 激酶活性或耗尽 RIPK3 并不总是得出涉及坏死性凋亡的结论的前提。此外,我们发现,与 cIAP1/2 耗竭相反,TAK1 激酶抑制诱导细胞质 RIPK1/Fas 相关死亡结构域/半胱天冬酶-8 凋亡 TNF 受体 1(TNFR1)复合物 IIb 的组装,而不影响 TNFR1 复合物 I 水平的 RIPK1 泛素化状态。这些结果表明,TAK1 募集到泛素(Ub)链,而不是 Ub 链本身,调节 RIPK1 对凋亡死亡触发的贡献。与此一致,我们发现,在通过 cIAP1/2 耗竭获得的 RIPK1 泛素化减少的情况下,仅抑制圆柱瘤抑制因子仅能为 TNF 介导的 RIPK1 依赖性凋亡提供保护,但在 TAK1 激酶抑制的情况下不能提供保护,再次表明 TAK1 在防止 RIPK1 依赖性凋亡方面起作用 RIPK1 泛素化下游。重要的是,我们发现 TAK1 的这一功能与其在经典核因子-κB(NF-κB)激活中的已知作用无关。因此,我们的研究报告了 TAK1 在调节 TNFR1 凋亡途径中早期 NF-κB 独立的细胞死亡检查点中的新功能。在两种 TNF 诱导的 RIPK1 激酶依赖性凋亡模型中,我们发现 RIPK3 独立于其激酶活性或完整 RHIM 结构域,有助于完全半胱天冬酶-8 激活。相比之下,RIPK3 通过充当细胞质死亡复合物组装的下游,可能通过活性氧的产生,参与半胱天冬酶-8 的激活。